Matt, I agree with some of your points, disagree on others. Your point about trials for device companies is off – FDA trials are kept “airtight” for many reasons – and it is in the company’s interest to ensure this to endure FDA and public scrutiny. And device companies don’t think they will fail; otherwise they wouldn’t spend the millions!
And it is true that far more devices have succeeded than failed, though this forum is about sharing ALL the experiences: good, bad and the “average” outcomes in between.
Quantitative outcome data is the Holy Grail. Yes, the clinical trials provide data, but it is less than ideal in terms of its “readability,” let along availability. Next year, as a newly formed non-profit, I’ll be tackling this issue and launching a rigorous patient survey. More on this in the coming months.
|